4.8 Article

Carnitine Palmitoyltransferase 1A Has a Lysine Succinyltransferase Activity

期刊

CELL REPORTS
卷 22, 期 6, 页码 1365-1373

出版社

CELL PRESS
DOI: 10.1016/j.celrep.2018.01.030

关键词

-

资金

  1. Susan G. Komen Foundation [CCR14300798]
  2. Eagles Cancer Research Fund
  3. Mayo Clinic Center for Biomedical Discovery
  4. Mayo Clinic Cancer Center
  5. Mayo Clinic Breast SPORE [P50CA-116201-10]
  6. Mayo Foundation for Education and Research
  7. NIH [T32-GM08685]
  8. NCI Cancer Center [P30-CA15083-40]
  9. NATIONAL CANCER INSTITUTE [P50CA116201] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Lysine succinylation was recently identified as a post-translational modification in cells. However, the molecular mechanism underlying lysine succinylation remains unclear. Here, we show that carnitine palmitoyltransferase 1A (CPT1A) has lysine succinyltransferase (LSTase) activity in vivo and in vitro. Using a stable isotope labeling by amino acid in cell culture (SILAC)-based proteomics approach, we found that 101 proteins were more succinylated in cells expressing wild-type (WT) CPT1A compared with vector control cells. One of the most heavily succinylated proteins in this analysis was enolase 1. We found that CPT1A WT succinylated enolase 1 and reduced enolase enzymatic activity in cells and in vitro. Importantly, mutation of CPT1A Gly710 (G710E) selectively inactivated carnitine palmitoyltransferase (CPTase) activity but not the LSTase activity that decreased enolase activity in cells and promoted cell proliferation under glutamine depletion. These findings suggest that CPT1A acts as an LSTase that can regulate enzymatic activity of a substrate protein and metabolism independent of its classical CPTase activity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据